Cardiac Biomarkers Market Report by Type (Troponins (T and I), Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), and Others), Location of Testing (Laboratory Testing, Point of Care Testing), Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), and Region 2024-2032
Market Report I 2024-01-30 I 141 Pages I IMARC Group
The global cardiac biomarkers market size reached US$ 10.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 21.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.6% during 2024-2032.
Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac troponins, creatine kinase (CK), ischemia-modified albumin (IMA), and myoglobin. Measurement and testing of these markers can help in diagnosing heart conditions like cardiac ischemia and acute coronary syndrome (ACS). At present, the triage and diagnostic systems used for determining the risk of these conditions are based on electrocardiograms (ECGs) and clinical history. However, these systems are insufficient and can lead to misdiagnosis or delay in treatment. As cardiac marker testing offers higher accuracy and can identify the conditions in the early stages of presentation, they are gaining traction across the globe. These markers can also help in monitoring the prognosis of these condition with greater accuracy and providing the most effective treatment to the patients.
Global Cardiac Biomarkers Market Drivers:
Over the past few years, there has been a rise in the number of patients suffering from ACS which has created a demand for cardiac marker testing at a global level. Other than this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. In addition, there are numerous private and public organizations which are investing in R&D activities to develop advanced technologies in the field of cardiac biomarkers. For instance, blood tests for high-sensitivity cardiac troponin I have been demonstrated to identify patients who are at a higher risk of a second heart attack. Moreover, high accuracy and rapid results offered by biomarker testing, coupled with the availability of affordable cardiac point-of-care testing, are some of the other factors which are contributing to the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiac biomarkers market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on type, location of testing, and application.
Breakup by Type:
Troponins (T and I)
Myocardial Muscle Creatine Kinase (CK-MB)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia Modified Albumin (IMA)
Others
Based on the type, the market has been segmented into troponins (T and I), myocardial muscle creatine kinase (CK-MB), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA) and others.
Breakup by Location of Testing:
Laboratory Testing
Point of Care Testing
Based on the location of testing, the market has been segmented into laboratory testing and point of care testing. Laboratory testing currently accounts for a larger share.
Breakup by Application:
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
Based on the application, the market has been segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. Myocardial infarction currently accounts for the highest share.
Regional Insights:
North America
Asia Pacific
Europe
Middle East and Africa
Latin America
Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for majority of the global share.
Competitive Landscape:
The report has also analyzed the competitive landscape of the market with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.
Key Questions Answered in This Report
1. What was the size of the global cardiac biomarkers market in 2023?
2. What is the expected growth rate of the global cardiac biomarkers market during 2024-2032?
3. What are the key factors driving the global cardiac biomarkers market?
4. What has been the impact of COVID-19 on the global cardiac biomarkers market?
5. What is the breakup of the global cardiac biomarkers market based on the location of testing?
6. What is the breakup of the global cardiac biomarkers market based on the application?
7. What are the key regions in the global cardiac biomarkers market?
8. Who are the key companies/players in the global cardiac biomarkers market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cardiac Biomarkers Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Type
5.5 Market Breakup by Location of Testing
5.6 Market Breakup by Application
5.7 Market Breakup by Region
5.8 Market Forecast
6 Market Breakup by Type
6.1 Troponins (T and I)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Myocardial Muscle Creatine Kinase (CK-MB)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Myoglobin
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Ischemia Modified Albumin (IMA)
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Location of Testing
7.1 Laboratory Testing
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Point of Care Testing
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Myocardial Infarction
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Congestive Heart Failure
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Acute Coronary Syndrome
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Atherosclerosis
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Asia Pacific
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Europe
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Middle East and Africa
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Latin America
9.5.1 Market Trends
9.5.2 Market Forecast
10 Global Cardiac Biomarkers Industry: SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Global Cardiac Biomarkers Industry: Value Chain Analysis
12 Global Cardiac Biomarkers Industry: Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Global Cardiac Biomarkers Industry: Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.2 Alere Inc.
14.3.3 Beckman Coulter
14.3.4 Becton, Dickinson And Co.
14.3.5 Biomerieux
14.3.6 Bio-Rad Laboratories
14.3.7 Randox Laboratories
14.3.8 Roche Diagnostics Corporation
14.3.9 Siemens Healthcare
14.3.10 Thermo Fisher Scientific
Figure 1: Global: Cardiac Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Cardiac Biomarkers Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Cardiac Biomarkers Market: Breakup by Type (in %), 2023
Figure 4: Global: Cardiac Biomarkers Market: Breakup by Location of Testing (in %), 2023
Figure 5: Global: Cardiac Biomarkers Market: Breakup by Application (in %), 2023
Figure 6: Global: Cardiac Biomarkers Market: Breakup by Region (in %), 2023
Figure 7: Global: Cardiac Biomarkers Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 8: Global: Cardiac Biomarkers Industry: SWOT Analysis
Figure 9: Global: Cardiac Biomarkers Industry: Value Chain Analysis
Figure 10: Global: Cardiac Biomarkers Industry: Porter's Five Forces Analysis
Figure 11: Global: Cardiac Biomarkers (Troponins) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Cardiac Biomarkers (Troponins) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Cardiac Biomarkers (Myoglobin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Cardiac Biomarkers (Myoglobin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Cardiac Biomarkers (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Cardiac Biomarkers (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Cardiac Biomarkers (Laboratory Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Cardiac Biomarkers (Laboratory Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Cardiac Biomarkers (Point of Care Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Cardiac Biomarkers (Point of Care Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Cardiac Biomarkers (Myocardial Infarction) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Cardiac Biomarkers (Myocardial Infarction) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Cardiac Biomarkers (Congestive Heart Failure) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Cardiac Biomarkers (Congestive Heart Failure) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Cardiac Biomarkers (Atherosclerosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Cardiac Biomarkers (Atherosclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Cardiac Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Cardiac Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: North America: Cardiac Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: North America: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Asia Pacific: Cardiac Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Asia Pacific: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Europe: Cardiac Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Europe: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Middle East and Africa: Cardiac Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Middle East and Africa: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Latin America: Cardiac Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Latin America: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Table 1: Global: Cardiac Biomarkers Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Cardiac Biomarkers Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Cardiac Biomarkers Market Forecast: Breakup by Location of Testing (in Million US$), 2024-2032
Table 4: Global: Cardiac Biomarkers Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Cardiac Biomarkers Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Cardiac Biomarkers Market Structure
Table 7: Global: Cardiac Biomarkers Market: Key Players
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.